EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunoglobulin genes and severity of COVID-19

Daniel Vázquez-Coto, Christine Kimball, Guillermo M Albaiceta, Laura Amado-Rodríguez, Marta García-Clemente, Juan Gómez, Eliecer Coto, Janardan P Pandey iD

Immunogenetics · 2024

DOI: 10.1007/s00251-024-01341-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunogenetics, 2024. Verfasst von Daniel Vázquez-Coto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, Oviedo, Spain. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Immunoglobulin G, Severity of Illness Index. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense, Instituto de Salud Carlos III, Medical University of South Carolina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is tremendous interindividual and interracial variability in the outcome of SARS-CoV-2 infection, suggesting the involvement of host genetic factors. Here, we investigated whether IgG allotypes GM (γ marker) 3 and GM 17, genetic markers of IgG1, contributed to the severity of COVID-19. IgG1 plays a pivotal role in response against SARS-CoV-2 infection. We also investigated whether these GM alleles synergistically/epistatically with IGHG3 and FCGR2A alleles—which have been previously implicated in COVID-19—modulated the extent of COVID-19 severity. The study population consisted of 316 COVID-19 patients who needed treatment in the intensive care unit of Hospital Universitario Central de Asturias. All individuals were genotyped for GM 3/17, IGHG3 hinge length, and FCGR2A rs1801274 A/G polymorphisms. Among the 316 critical patients, there were 86 deaths. The risk of death among critical patients was significantly higher in subjects with GM 17 (IgG1) and short hinge length (IgG3). GM 17-carriers were at almost three-fold higher risk of death than non-carriers ( p < 0.001; OR = 2.86, CI 1.58–5.16). Subjects with short hinge length of IgG3 had a two-fold higher risk of death than those with medium hinge length ( p = 0.01; OR = 2.16, CI 1.19–3.90). GM 3/3 and IGHG3 (MM) genotypes were less frequent among death vs. survivors (9% vs 36%, p < 0.001) and associated with protective effect (OR = 0.18, 95% CI = 0.08–0.39). This is the first report implicating IgG1 allotypes in COVID-19-spurred death. It needs to be replicated in an independent study population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Immunoglobulin GSeverity of Illness IndexReceptors, IgGHumansMaleFemaleMiddle AgedAgedImmunoglobulin Gm AllotypesGenotypePolymorphism, Single NucleotideAdultGenes, ImmunoglobulinAlleles

Stichwörter der Autor:innen

FCGR2AADCCCOVID-19GM allotypesHumoral immunitySARS-CoV-2

Substanzen

Immunoglobulin GReceptors, IgGImmunoglobulin Gm AllotypesFCGR2A protein, human

Autor:innen und Institutionen

  • Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, Oviedo, Spain.
  • Genética Molecular, Hospital Universitario Central Asturias, Oviedo, Spain.
  • Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, 29425, USA.
  • Unidad de Cuidados Intensivos Cardiológicos, Hospital Universitario Central Asturias, Oviedo, Spain.
  • Universidad de Oviedo, Oviedo, Spain.
  • CIBER-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Janardan P Pandey

Förderung

  • U.S. Department of Defense
  • Instituto de Salud Carlos III
  • Medical University of South Carolina

Zitieren

APA

Vázquez-Coto, D., Kimball, C., Albaiceta, G. M., Amado-Rodríguez, L., García-Clemente, M., Gómez, J., Coto, E., & Pandey, J. P. (2024). Immunoglobulin genes and severity of COVID-19. Immunogenetics. https://doi.org/10.1007/s00251-024-01341-z

Vancouver

Vázquez-Coto D, Kimball C, Albaiceta GM, Amado-Rodríguez L, García-Clemente M, Gómez J, et al. Immunoglobulin genes and severity of COVID-19. Immunogenetics. 2024. doi:10.1007/s00251-024-01341-z

BibTeX
@article{VzquezCoto2024,
  author = {Vázquez-Coto, Daniel and Kimball, Christine and Albaiceta, Guillermo M and Amado-Rodríguez, Laura and García-Clemente, Marta and Gómez, Juan and Coto, Eliecer and Pandey, Janardan P},
  title = {Immunoglobulin genes and severity of COVID-19},
  journal = {Immunogenetics},
  year = {2024},
  doi = {10.1007/s00251-024-01341-z}
}
Kostenlos starten →